NCT02985034 Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT Status COMPLETED Phase N/A
NCT02977754 18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib Status COMPLETED Phase N/A
NCT02971696 Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. Status COMPLETED Phase PHASE3
NCT02966223 A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver Status TERMINATED Phase NA
NCT02935478 Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation Status SUSPENDED Phase NA
NCT02898415 Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) Status COMPLETED Phase N/A
NCT02833298 Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening Status COMPLETED Phase NA
NCT02715492 Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. Status UNKNOWN Phase PHASE3
NCT02705105 Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02675881 Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®) Status COMPLETED Phase NA
NCT02659852 A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction Status UNKNOWN Phase NA
NCT02645981 Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT02575339 MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02561546 p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT02471313 Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization Status COMPLETED Phase PHASE2
NCT02415283 OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI Status UNKNOWN Phase N/A